Live
Endpoints NewsTravere pays Everest $112M upfront to grow rare kidney disease pipelineEndpoints NewsLegend Biotech shares first in vivo CAR-T data, its next act after CarvyktiFierceBiotechFulcrum scraps SCD program, considers options after FDA takes hard line on safety risksFierceBiotechASCO: Cardiff posts updated colorectal cancer data ahead of pivotal pushPharmaVoiceAs amyloid falls out of favor, here’s where Alzheimer’s R&D is headed nextLabiotechThe biggest biotech funding rounds in May 2026BioWorldOther news to note for June 2, 2026FierceBiotechASCO: Bristol Myers’ $800M bispecific ADC aces China breast cancer study, putting TROP2 drugs on noticeFierceBiotechASCO: Celcuity dares to dream of becoming $10B company after breast cancer win over PiqrayFierceBiotechMindMaze Therapeutics culls program, ends legacy ops from Relief merger to cut costsBioPharma DiveAbiVax falls as safety worries cloud ‘landmark’ immune drug resultsEndpoints News#ASCO26: Celcuity plans another FDA filing after positive breast cancer readout
Illumina Apr 17, 2026

Final Trades: Netflix, BlackRock, Illumina and UPS - CNBC

Final Trades: Netflix, BlackRock, Illumina and UPS - CNBC

Original
Body unavailable. Use the original source.